250 filings
Page 4 of 13
8-K
85eb6 b7m5
14 May 20
Other Events
4:16pm
8-K
oahxrw2
24 Apr 20
Other Events
10:04am
8-K
eg9e8
2 Apr 20
Departure of Directors or Certain Officers
4:32pm
8-K
ghp80p
27 Mar 20
Departure of Directors or Certain Officers
4:41pm
8-K
up2v6qk4ut k8atjoz
18 Mar 20
NewLink Genetics Stockholders Approve Merger with Lumos Pharma
4:37pm
8-K
2ukz0duj06dkx7
28 Feb 20
NewLink Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
9:08am
8-K
1m479uow9x92j
20 Dec 19
Regulation FD Disclosure
4:21pm
8-K/A
14zr7m1qk cjvni
20 Nov 19
Regulation FD Disclosure
6:11am
8-K
38bo8qw49c
20 Nov 19
Entry into a Material Definitive Agreement
6:08am
8-K
kp1 r0pm0
12 Nov 19
Other Events
9:11am
8-K
dokc1q 9q58mou
6 Nov 19
NewLink Genetics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
8:34am
8-K
g0mkw fkat38e4lf
30 Sep 19
Entry into a Material Definitive Agreement
12:00am
8-K
3g3ea0q4vev9agqsp
17 Sep 19
Other Events
5:16pm
8-K
r1coiht25frb65 uh2
2 Aug 19
Departure of Directors or Certain Officers
4:24pm
8-K
l4l1pr yvly
30 Jul 19
NewLink Genetics Provides Corporate Update and Reports Second Quarter 2019 Financial Results
8:36am
8-K
dbdjysxnyylpwkov m6i
23 May 19
NewLink Genetics Presents Updated NLG802 Results at the Immuno-Oncology 2019 World Congress
8:40am
8-K
bhaihcbib60 7rxo
15 May 19
Submission of Matters to a Vote of Security Holders
5:02pm
8-K
ms55el3tt42k0rry p7
8 May 19
NewLink Genetics Reports First Quarter 2019 Financial Results and Provides Clinical Activities Update
4:33pm
8-K
4bhec 7ubc7b8utp5xc
2 Apr 19
NewLink Genetics Presents Encouraging Phase 2 Results for NLG207 in Ovarian Cancer at AACR 2019
8:32am
8-K
2uk9og3auikg3jt3feqd
5 Mar 19
Departure of Directors or Certain Officers
4:27pm